✦ LIBER ✦

MP70-01 EARLY EXPERIENCE OF RADIUM-223 TREATMENT FOR METASTATIC CASTRATE RESISTANT PROSTATE CANCER: A PRELIMINARY REPORT

✍ Scribed by Bienz, Marc; Alom, Modar; Mouravieva, Vladimira; Zehel, Debby; Pieczonka, Christopher; Albala, David; Williams, Howard; Mouraviev, Vladimir; Mariados, Neil

Book ID: 122216330
Publisher: Lippincott Williams and Wilkins
Year: 2014
Tongue: English
Weight: 188 KB
Volume: 191
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2014.02.2200

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP70-12 AN INDIRECT TREATMENT COMPARISON

MP70-12 AN INDIRECT TREATMENT COMPARISON AND COST-EFFECTIVENESS ANALYSIS OF ABIRATERONE ACETATE AND ENZALUTAMIDE FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER POST CHEMOTHERAPY

✍ Thompson, Melissa; Li, Tracy; Todd, Mary Beth; Yu, Margaret K.; Kheoh, Thian; He 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 145 KB

7003 A double blind, randomised, dose fi

7003 A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005–003680–22

✍ Parker, C.; Hoskin, P.; Pascoe, S.; Chodack, A.; O'Sullivan, J.M.; Germá, J.R.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

130 Overall survival benefit and impact

130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)

✍ C. Parker; D. Heinrich; S.I. Helle; J.M O'Sullivan; S Fossä; A. Chodacki; T. Dem 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 107 KB